|
2023 Conference Publication Immune profiling of immunotherapy and adjuvant chemotherapy pretreatment NSCLC tissues by CODEXMonkman, James, Moradi, Afshin, O'Leary, Connor, Wu, Zhenqin, Hamel, Steven, Mason, David, Schneider, Fabian, Mansfield, James Robert, Meyer, Aaron, O'Byrne, Ken and Kulasinghe, Arutha (2023). Immune profiling of immunotherapy and adjuvant chemotherapy pretreatment NSCLC tissues by CODEX. AACR Annual Meeting 2023, Orlando, FL United States, 14-19 April 2023. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2023-4627 |
|
2023 Conference Publication Polo-like kinase-1 is a novel biomarker in resected non-small cell lung cancer treated with adjuvant platinum-based chemotherapyO'Leary, Connor, Monkman, James, Richard, Derek, O'Byrne, Kenneth, Kulasinghe, Arutha and Adams, Mark (2023). Polo-like kinase-1 is a novel biomarker in resected non-small cell lung cancer treated with adjuvant platinum-based chemotherapy. Australian Lung Cancer Conference 2023, Gold Coast, QLD Australia, 15-17 February 2023. Richmond, VIC Australia: John Wiley & Sons. |
|
2021 Conference Publication Characterizing the Tumour-Immune Microenvironment in EGFR Mutant NSCLCMonkman, J., O’Leary, C., Richard, D., O'Byrne, K. and Kulasinghe, A. (2021). Characterizing the Tumour-Immune Microenvironment in EGFR Mutant NSCLC. 2021 World Conference on Lung Cancer, Virtual, 8-14 September 2021. New York, United States: Elsevier. doi: 10.1016/j.jtho.2021.08.605 |
|
2021 Conference Publication Identification of ctDNA using MassARRAY Technology in a Cross-Sectional Study of NSCLC PatientsKulasinghe, A., Monkman, J., Dutta, S., O’Leary, C., Ladwa, R. and O'Byrne, K. (2021). Identification of ctDNA using MassARRAY Technology in a Cross-Sectional Study of NSCLC Patients. 2021 World Conference on Lung Cancer, Virtual, 8-14 September 2021. New York, United States: Elsevier. doi: 10.1016/j.jtho.2021.08.375 |
|
2021 Conference Publication The role of the immune microenvironment in EGFR mutant NSCLCMonkman, James, Kulasinghe, Arutha, O’Leary, Connor, Richard, Derek and O’Byrne, Ken (2021). The role of the immune microenvironment in EGFR mutant NSCLC. 19th Annual British Thoracic Oncology Group Conference, Online, 22-23 April 2021. Shannon, Ireland: Elsevier Ireland. doi: 10.1016/s0169-5002(21)00204-x |
|
2021 Conference Publication The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)Kulasinghe, Arutha, Monkman, James, Dutta, Sanjay, O’Leary, Connor, Ladwa, Rahul and O’Byrne, Ken (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). 19th Annual British Thoracic Oncology Group Conference 2021, Virtual, 22-23 April 2021. Shannon, Ireland: Elsevier Ireland. doi: 10.1016/s0169-5002(21)00199-9 |
|
2021 Conference Publication The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)Kulasinghe, Arutha, Monkman, James, Dutta, Sanjay, O'Leary, Connor, Ladwa, Rahul and O'Byrne, Ken (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). 19th Annual British Thoracic Oncology Group Conference 2021, Virtual, 22-23 April 2021. Shannon, Ireland: Elsevier. doi: 10.1016/S0169-5002(21)00199-9 |
|
2021 Conference Publication TS01.06 High-Plex Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC)Kulasinghe, A., Monkman, J., Taheri, T., Warkiani, M., O’leary, C., Ladwa, R., Richard, D. and O'Byrne, K. (2021). TS01.06 High-Plex Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC). 2020 North America Conference on Lung Cancer, Virtual, 16-17 October 2020. New York, United States: Elsevier. doi: 10.1016/j.jtho.2020.10.098 |
|
2020 Conference Publication Highly multiplexed digital spatial profiling of the tumor microenvironment of non-small-cell lung cancer (NSCLC)Kulasinghe, Arutha, O’Leary, Connor, Ladwa, Rahul, Warkiani, Majid and O’byrne, Kenneth (2020). Highly multiplexed digital spatial profiling of the tumor microenvironment of non-small-cell lung cancer (NSCLC). 35th Anniversary Annual Meeting (SITC 2020), Virtual, 9-14 November 2020. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2020-sitc2020.0043 |
|
2020 Conference Publication Limited benefit of adjuvant chemotherapy in resected Epidermal Growth Factor Receptor (EGFR) positive non-small cell lung cancer (NSCLC)O'Leary, Connor, Fletcher, James, Yuile, Alexander, Xu, Wen, Ladwa, Rahul, McGrath, Margaret, Pavlakis, Nick, Hughes, Brett, McCaffery, Elizabeth and O'Byrne, Kenneth (2020). Limited benefit of adjuvant chemotherapy in resected Epidermal Growth Factor Receptor (EGFR) positive non-small cell lung cancer (NSCLC). Medical Oncology Group of Australia Annual Scientific Meeting, Virtual, Australia, 14-21 August 2020. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. |
|
2020 Conference Publication Culture of circulating tumour cells derived from non-small cell lung cancerO'Byrne, Kenneth John, Kapeleris, Joanna, Kulasinghe, Arutha, Warkiani, Majid E., O'Leary, Connor Gerard, Ladwa, Rahul, Vela, Ian, Leo, Paul, Sternes, Peter and Punyadeera, Chamindie (2020). Culture of circulating tumour cells derived from non-small cell lung cancer. 2020 ASCO Annual Meeting, Online, 30 May 2020. Alexandria, VA USA: American Society of Clinical Oncology. doi: 10.1200/jco.2020.38.15_suppl.e21692 |
|
2018 Conference Publication The impact of the 21 gene recurrence score (RS) on chemotherapy (CHemoRx) prescribing in hormone receptor (HR) positive, lymph node positive (LN+) early-stage breast cancer (BC) in Ireland: A national, multi-centre, prospective study (CTRIAL-IE 15-34)Hassan, A., Keegan, N., O’Leary, C., McSorley, L., Mahgoub, T., O’Reilly, S., Walshe, J., Kennedy, M.J., Coate, L., O’Connor, M., Keane, M., Kelly, C.M., Milewski, M., Molloy, S., Eagan, K., Murphy, V., Breathnach, O.S., Grogan, L., Hennessy, B. and Morris, P.G. (2018). The impact of the 21 gene recurrence score (RS) on chemotherapy (CHemoRx) prescribing in hormone receptor (HR) positive, lymph node positive (LN+) early-stage breast cancer (BC) in Ireland: A national, multi-centre, prospective study (CTRIAL-IE 15-34). 43rd ESMO Congress (ESMO 2018), Munich, Germany, 19–23 October 2018. Amsterdam, Netherlands: Elsevier. doi: 10.1093/annonc/mdy270.203 |
|
2018 Conference Publication Rectal cancer in the elderly: A review of treatment variances between younger and older patientsCorrigan, Lynda, O'Leary, Connor Gerard, Kroes, Jeska, Calvert, Paula, O'Connor, Miriam, Martin, Petra, Cooke, Fiachra and Horgan, Anne M. (2018). Rectal cancer in the elderly: A review of treatment variances between younger and older patients. Cancers of the Colon, Rectum, and Anus, Unknown, Unknown. American Society of Clinical Oncology (ASCO). doi: 10.1200/jco.2018.36.4_suppl.839 |
|
2017 Conference Publication Oncotype DX score, menopausal status and body mass indexPicardo, S., Sui, J., Greally, M., Woulfe, B., Prior, L., Corrigan, L., O'Leary, C., Mullally, W., Walshe, J., McCaffrey, J., O'Connor, M., O'Mahony, D., Coate, L., Gupta, R. and O'Reilly, S. (2017). Oncotype DX score, menopausal status and body mass index. 42nd ESMO Congress (ESMO 2017), Madrid, Spain, 8-12 September 2017. Amsterdam, Netherlands: Elsevier. doi: 10.1093/annonc/mdx362.043 |
|
2017 Conference Publication Reduced-intensity bevacizumab in progressive glioblastoma multiforme (GBM) is associated with similar overall survival versus standard-dosingGleeson, J. P., Keegan, N., Harrold, E., Kamel, D., Karadawi, N., Mammadov, E., Kelly, D., O'Leary, C., O'Halloran, P., Egan, K., Molloy, S., Mac Nally, S., Hennessy, B. T., Breathnach, O. S., Grogan, W. and Morris, P. G. (2017). Reduced-intensity bevacizumab in progressive glioblastoma multiforme (GBM) is associated with similar overall survival versus standard-dosing. 42nd European Society for Medical Oncology Congress (ESMO), Madrid, Spain, 8-12 September 2017. Amsterdam, Netherlands: Elsevier. doi: 10.1093/annonc/mdx366.023 |
|
2017 Conference Publication Long-term Trastuzumab treatment: can we ever stop?Keane, F., Walsh, E., Sui, J., Marks, S., O'leary, C., Gleeson, J., Keane, M. and O'Reilly, S. (2017). Long-term Trastuzumab treatment: can we ever stop?. Primary Therapy of Early Breast Cancer 15th St.Gallen International Breast Cancer Conference, Vienna, Austria, 15-18 March 2017. London, United Kingdom: Churchill Livingstone. doi: 10.1016/s0960-9776(17)30225-4 |
|
2017 Conference Publication 13: Epidermal growth factor receptor (EGFR) mutated advanced squamous cell lung cancer – treatment beyond progressionO'Leary, C.G., Corrigan, L., Rehman, Z., Kroes, J., Murphy, G., Mannion, J., O'Connor, M., Horgan, A. and Calvert, P. (2017). 13: Epidermal growth factor receptor (EGFR) mutated advanced squamous cell lung cancer – treatment beyond progression. 15th Annual British Thoracic Oncology Group Conference 2017, Dublin, Ireland, 25-27 January 2017. Shannon, Ireland: Elsevier. doi: 10.1016/s0169-5002(17)30063-6 |
|
2017 Conference Publication Non small cell lung cancer mutational testing in the South East of IrelandO'Leary, C. G., Kroes, J., Murphy, G., Doyle, M., Corrigan, L., Rehman, Z., Mannion, J., Foley, S., Rogan, M., O'Connor, M., Horgan, A. and Calvert, P. (2017). Non small cell lung cancer mutational testing in the South East of Ireland. 15th Annual British Thoracic Oncology Group Conference 2017, Dublin, Ireland, 25-27 January 2017. Shannon, Ireland: Elsevier. doi: 10.1016/s0169-5002(17)30093-4 |
|
2016 Conference Publication The accuracy of pre-operative MRI in predicting the rectal cancer tumour stage, node status and complete clinical response in patients who have undergone neoadjuvant chemoradiotherapy using histopathologic analysis as the reference standardNugent, Killian, Harrold, Emily, Sugrue, Gavin, McDermott, Ronan, Prior, Lisa Mary, Watson, Geoffrey Alan, Gleeson, Jack Patrick, O'Leary, Connor Gerard, Kelly, Deirdre and Lim, Marvin Chang Jui (2016). The accuracy of pre-operative MRI in predicting the rectal cancer tumour stage, node status and complete clinical response in patients who have undergone neoadjuvant chemoradiotherapy using histopathologic analysis as the reference standard. Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, IL, United States, 3-7 June 2016. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/jco.2016.34.15_suppl.e15142 |
|
2016 Conference Publication Does immune checkpoint inhibitor-induced thyroid dysfunction impact on side effect profile? A restrospective cohort studyGleeson, Jack Patrick, Ellis, Haley, Prior, Lisa Mary, Watson, Geoffrey Alan, Nugent, Killian, Lim, Marvin Chang Jui, Harrold, Emily, O'Leary, Connor Gerard, Kelly, Deirdre, Kelly, Catherine Margaret and McCaffrey, John (2016). Does immune checkpoint inhibitor-induced thyroid dysfunction impact on side effect profile? A restrospective cohort study. Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, IL, United States, 3-7 June 2016. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/jco.2016.34.15_suppl.e14535 |
